MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Cabaletta Bio, Inc. Common Stock

CABA

#3709
Cabaletta Bio, Inc. Common Stock
3.32
0.00%
Sector:
Base:
Profit Currency:
Daily Range
3.32
3.32
Year Range
0.99
3.78
Daily Change
0.00%
Monthly Change
+9.57%
6 month change
+121.33%
Year Change
+81.42%
Previous Close
3.32
Open
3.32
Bid
Ask
Low
3.32
High
3.32
Volume
38
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CABA
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Zacks Zacks
AVXL CABA
2026.02.12
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
Zacks Zacks
CABA
2026.01.30
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now?
Seeking Alpha Seeking Alpha
CABA
2026.01.27
Cabaletta Bio: Do You Buy With The Insiders? (NASDAQ:CABA)
Zacks Zacks
CABA CELC
2026.01.27
Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?
Investing Investing
CABA
2026.01.27
Guggenheim reiterates Buy rating on Cabaletta Bio stock, citing commercial plan
Benzinga Benzinga
IOBT CABA MRAM MRNA MRK
2026.01.22
Why High Roller Technologies Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket - American Rebel Holdings (NASDAQ:AREB), Aura Biosciences (NASDAQ:AURA)
Investing Investing
CABA
2026.01.22
Gerard, Cabaletta bio general counsel, buys $14.9k in CABA
Investing Investing
CABA
2026.01.22
Cabaletta Bio (CABA) CEO Nichtberger buys $100,777 in shares
Investing Investing
CABA
2026.01.22
Simon Mark, Cabaletta bio director, buys $25,261 in shares
Investing Investing
CABA
2026.01.16
Cabaletta Bio stock rating reiterated by Cantor Fitzgerald on IND clearance
Investing Investing
CABA
2026.01.12
Cellares’ cell therapy manufacturing platform gets FDA clearance
Seeking Alpha Seeking Alpha
CABA BMY RNAC
2025.11.14
Kyverna Stock: Immune Reset Is Clinically Validated, Market Ignores Potential

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd